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ABSTRACT
Introduction: Group B Streptococcus (GBS), infection and recurrence in newborns and pregnant women can lead to 
chronic medical illness resulting in significant morbidity, and mortality. Pathogenesis of GBS may be due to reasons 
such as activation of the immune system, followed by the production of inflammatory markers and toxic components 
by immune cells including macrophages. Methods: The studies on invasive and colonizing GBS strains inoculated 
either with peripheral or brain macrophages, the expression of nitric oxide (NO), cell viability, and CD40 were 
also measured by Griess assay, methyl tetrazolium assay (MTT), and flow cytometry, respectively. Furthermore, the 
clinical manifestations of the selected patients were also assessed for this study. Results: Outcome of inflammatory 
markers studies, after GBS inoculation indicated that, invasive GBS strains induced higher inflammatory markers 
in comparison to colonizing GBS strains. Furthermore, patients’ clinical data showed that patients with invasive 
GBS infections had severe condition unlike among patients with colonizing GBS strains. The fatality rate in patients 
with invasive GBS strain were 30.8% while there was no death among carriers. Conclusion: This study, aimed to 
understand the immune response to GBS, and strengthen the knowledge on GBS pathogenesis. It was concluded 
that invasive GBS strains not only showed higher expression of inflammatory markers on immune cells but also had 
higher pathogenesis effect in comparison to colonizing GBS strains. 
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Streptococcus agalactiae, the group B streptococcus 
(GBS) is a gram-positive, encapsulated bacterium, 
displays beta-hemolytic activity on blood agar. It is a 
commensal flora in genital and lower gastrointestinal 
tract in 10-40% of every healthy adult (1). However, 
colonization of GBS in vagina during pregnancy can 
be clinically significant because of its association 
with neonatal meningitis and septicemia (2). In the 
last two decades, the percentage of GBS infection is 
found increasingly in adults, particularly those with 
other comorbidities, such as cirrhosis, renal failure and 
diabetes mellitus (3). 
Pathogenesis of GBS infection involves several processes, 
such as inducing the production of various inflammatory 
markers and secretion of toxic components that are 
harmful to the human body. Macrophages plays a vital 
role in this response by production of these markers 
on their own as well as by stimulating other immune 
cells to do so (4, 5). The pro-inflammatory markers and 
toxic components such as reactive oxygen and nitrogen 
radicals produced by macrophages on exposure to GBS 
pathogens could cause cell and tissue injury in the 
human body (6, 7). 
Mal J Med Health Sci 13(1): 55-60, Jan 201756
Malaysian Journal of Medicine and Health Sciences (ISSN 1675-8544)
Understanding the pathogenesis in GBS infections is 
pivotal for the successful intervention at various course of 
the disease. Previous research has been done on invasive 
and colonizing GBS strains, however, on different 
classifications such as hemolytic and non-hemolytic 
GBS strains, or based on patients’ symptoms. In the 
present study, we are taking an alternative approach by 
describing GBS strains which were collected from blood 
as invasive GBS strains, whereas GBS strains which were 
collected from high vaginal swab (HVS) as colonizing 
GBS strains. The purpose of this study is to add value 
to the previous works, by evaluating the differences 
in human immune inflammatory response elicitation, 
after inoculation of invasive and colonizing strains of 
GBS in vitro with macrophages. It can be hypothesized 
that there are differences between the colonizing and 
invasive GBS strains in their pathogenesis. Patients’ 
clinical data were also collected and evaluated to see 




BV-2 cells (transformed murine microglia cell line), 
and RAW 264.7 cells (transformed murine macrophage 
cell line) as representative for brain and peripheral 
macrophages respectively, were cultured in Dulbecco’s 
Modified Eagle Medium (DMEM) with high glucose, in 
5% heat-inactivated Fetal Bovine Serum (FBS) for BV-2 
cells and 10% FBS for RAW 264.7 cells, incubated 
at 37°C with 5% CO2. The cells were washed with 
phosphate buffered saline (PBS) twice and trypsinized 
with 0.25% Trypsin-EDTA solution. Cells with more 
than 95% viability (measured by trypan blue staining), 
were seeded into 24-well plate, 96- well plate, and 
6-well plate for performing Griess assay, methyl 
tetrazolium (MTT) assay, and immunophenotyping, 
respectively, at the optimized cell seeding densities. In 
order to maximize the accuracy across different passage 
numbers, the passage number of used BV-2 and RAW 
264.7 cells was restricted within five passage number 
difference in the experiments. 
Bacterial culture, heat-killing, and inoculation 
Sixteen different invasive GBS strains, and 15 different 
colonizing GBS strains, as well as Streptococcus 
agalactiae cultures (ATCC® 13813™), were grown on 
sheep blood agar followed by an overnight incubation, 
and the colonies were re-suspended in Brain Heart 
Infusion (27 g/mL of BHI powder in dH2O ;OXOID; Cat 
No. CM 1135). The cultures were incubated at 37°C 
overnight and diluted in BHI to acquire appropriate 
bacterial density based on 1.0 McFarland standard, 
and stored in 4°C. Bacterial densities was optimized 
separately for each assay. GBS cultures were then heat 
killed by boiling for 30 minutes. The absence of any 
viable bacteria after the heat killing process was ensured 
by culturing on Columbia agar with 5% sheep blood at 
37°C incubator for three days. If there was no bacterial 
growth, GBS suspensions were used for cell treatment, 
however if bacterial growth was observed, the heat-
killing procedure was repeated. The cells treated with 
lipopolysaccharide (with the optimized concentration 
for each assay) were used as positive control for all the 
assays. 
Griess assay 
Nitric oxide was measured by the Griess assay. Griess 
reagent was prepared by dissolving 1% sulfanilamide 
(Sigma, Batch No. 126K0001) and 0.1 % N-1-naphthyl-
ethylenediamine hydrochloride (Sigma, Cat. No. 
222488) in phosphoric acid. Two hundred microliter 
of supernatant from each well of the 24-well plate 
(bacterial treated cells, LPS treated cells and non-
treated cells) was transferred into an eppendorf tube, 
and centrifuged at 24, 48, and 72 hours for 4 minutes 
with 14000 rpm and 50 μL of each sample was added in 
triplicate to a 96-well plates. Equal volume of prepared 
Griess reagent was added to the wells, and the OD of the 
samples was read by Dynex MRX II microplate reader 
at 530 nm wavelength. The NO levels were estimated 
by comparing the samples reading to the standard curve 
generated using serially diluted NaNO2. 
Methy tetrazolium (MTT) assay 
Cell viability was measured by the MTT assay. MTT 
reagent was prepared by dissolving 5 mg/mL of MTT 
powder in dH2O (Amresco, LOT No. 1247B021). MTT 
assay was performed at 72 hours by adding MTT reagent 
to the cells and the cells were incubated for 3 hours at 
37°C with 5% CO2 in a humidified incubator. Afterwards, 
the culture supernatant was removed and DMSO was 
added to the wells and plates were incubated in the 
dark for 10 minutes and OD was read at 490 nm by 
Dynex MRX II microplate reader. Viability percentage 
was calculated with reference to a comparison between 
treated cells and untreated cells as control. 
Analysis of CD40 expression 
CD40 expression was analyzed on RAW 264.7 cells 
72 hours post exposure to the GBS strains. Cells were 
harvested using trypsin and aliquoted into FACS 
tubes (0.5×106 cells/tube) and rinsed with 0.2% BSA 
(Amresco, LOT No. 1621C094) in PBS at 2000 rpm for 5 
minutes. The cells were resuspended in 0.2% BSA/PBS, 
and mouse serum (AbDseroTec; Datasheet C11SCZ) was 
added to the cells, to block the unspecific bindings. The 
cells were incubated at room temperature for 15 minutes, 
and stained with CD40-FITC Ab (BD Pharminogen 
FITC Hamster Anti-Mouse; LOT No. 18883). The cells 
were incubated at 4° C in the dark for 20 minutes, and 
resuspended in 0.2% BSA/PBS after being centrifuged at 
2000 rpm for 5 minutes. CD40 expression was acquired 
by recording 10000 events per sample using BD FACS 
Calibur and analyzed with CellQuest Pro software (BD) 
at 24 hours of treatment. 
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Fig1. Inflammatory marker evaluation, produced by macrophages, after inoculation of GBS. (A)NO production: The 
cell density of BV-2 and RAW 264.7 cells were 25000 cells/well and 50000 cells/well respectively. (B) Viability 
measurement: The cell density of BV-2 and RAW 264.7 cells were 6250 cells/well and 12500 cells/well respectively. 
(C) Evaluation of CD40 expression: The cell density of RAW 264.7 was 0.8×106 cells/well. 
Ethical clearance 
Ethical clearance was obtained from ethic committees 
of Universiti Putra Malaysia (UPM/FPSK/PADS/
T7-MJKEtikaPer/F01(LECT(JMPP)_OKT(10)01) and 
Universiti Kebangsaan Malaysia Medical Centre (FF-
196-2011).
Clinical data evaluation 
In order to enhance the accuracy of our results in terms 
of finding any correlation between the inflammatory 
markers and patient’s symptoms, patient’s clinical data 
was collected along with the samples from Universiti 
Kebangsaan Malaysia Medical Centre. It was aimed 
to assess whether the invasive GBS strains isolated 
from patients with severe symptoms, induced higher 
inflammatory markers expression, in comparison to 
colonizing GBS strains which were isolated from 
asymptomatic patients. 
Statistical analysis 
Experimental data are expressed as mean ± SD. The 
statistical analysis was performed by using Student’s 
t-test. Values of P < 0.05 were considered statistically 
significant. 
RESULTS
Inflammatory markers analysis 
Bacterial density was optimized before inoculation with 
BV-2 and RAW 264.7 cells. Both invasive and colonizing 
GBS strains induced NO production in BV-2 and RAW 
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264.7 cells at all time points tested. At 48 hours, NO 
levels in RAW 264.7 cells induced by invasive GBS 
strains were higher than those induced by colonizing 
GBS strains (46.35 ± 25.11 μM NO compared to 28.3 
± 20.67 μM NO respectively; P value <0.05) (Figure 
1A). Moreover, results of viability measurement showed 
that there was a significant decrease in BV-2 and 
RAW 264.7 cell viability after inoculation of invasive 
GBS heat killed strains (to 22.7 ± 16.9% and 50.25 ± 
11.16% respectively), in comparison to the cell viability 
after inoculation of colonizing GBS heat killed strains 
(to 46.01 ± 26.54% and 71.21 ± 17.49% respectively) 
by 72 hours (P < 0.01) (Figure 1B). RAW 264.7 cells 
also increased expression of CD40 following LPS 
stimulation, indicating microglia activation. Similar to 
NO expression, invasive GBS strains appeared to induce 
higher CD40 expression (40.95 ± 11.98%; Figure 1C) 
compared to colonizing GBS heat killed strains (35.72 
± 7.44%) although the difference was not statistically 
significant.
Clinical data evaluation 
Among 17 patients with invasive GBS infections, no 
data were available for four patients. The clinical 
presentations are listed in Table 1 and presented as 
follows: septicemia (n = 6, 46.2%), pneumonia (n = 
3, 23.1%), peritonitis (n = 3, 23.1%), meningitis (n = 
1, 7.7%) and prematurity (n=1, 7.7%). There were 
only one case of meningitis and prematurity. The most 
common clinical syndrome among all the patients was 
septicemia. Of the three cases of pneumonia, one was 
community-acquired and two were hospital-acquired. 
The underlying medical conditions of all patients are 
shown in Table 2 and all patients had more than two 
underlying conditions. All patients survived except 
four patients (30.9%) with the cause of brain abscess, 
peritonitis, septicemia in three adults and prematurity 
in one neonate. On the other hand, among 14 carriers, 
no data was available for one patient. Out of the 13 
cases, eleven (84.6%) were in the postpartum period 
with the history of GBS positive in previous pregnancy 
Fig 2. Immunophenotyping assay to measure CD40 expression in RAW 264.7 cells, after GBS inoculation. A) 
Negative control 1. B) Negative control 2. C) Positive control. D), and E) Invasive GBS strains-treated cells. F), G), H), 
I), J), K), and L) Colonizing GBS strains-treated cells. The recorded events were 10000.
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in two (15.4%) cases. In two (15.4%) pregnant women, 
the baby was delivered via EMLSCS (one due to fetal 
distress and one due to leaking liquor) and in one (7.7%) 
pregnant women, there was the presence of PROM < 18 
hours. There was one case of placenta praevia and two 
cases of STD (one had aspirate pneumonia) in women 
with postpartum condition. In the case of non-pregnant 
women (n=2, 15.4%) with colonizing GBS strain, one 
presented with uterine fibroid and one had UTI (Table 
2). There was no death and all patients survived. 
DISCUSSION
The foremost research on oxidative burst, parallelly 
with phagocytosis on monocytes, induced by GBS, was 
done by McCloskey et al. in 2000 to measure reactive 
oxygen species (8). Oxidative burst has not been clearly 
investigated in monocytes/macrophages inoculated by 
GBS in previous research. However, it has been done on 
other bacteria such as Salmonella typhimurium, Listeria 
monocytogenes, Escherichia coli, and Staphylococcus 
aureus (8). In the previous studies, it has been shown 
that NO induced by GBS, plays a crucial role in the 
brain injury (9). Moreover, in a study by Ulett et al. 
in 2005, was shown that GBS-induced macrophages, 
had a significant increase in NO production at 72 hrs 
(10). In addition, all the methods which were used 
for measuring NO were listed by Mur and colleagues 
in 2011, although NO electrodes and Griess assay 
are preferred (11). Ring et al. in 2000 reported that 
NO production by RAW 264.7 cells was significantly 
higher after inoculation of invasive (hemolytic) GBS 
strains (even in absence of stimuli), in comparison to 
non-invasive (non-hemolytic) GBS strains (even after 
adding stimuli) (12). In the current study, GBS strains, 
were classified based on where they were isolated from, 
invasive GBS strains, induced higher NO production, in 
comparison to colonizing GBS strains. 
MTT assay was optimized by Gerlier et al. in 1986 on 
various cells (13). In addition, the dyes used for cell 
viability measurement were optimized by Skehan et 
al. in 1990. In previous studies, microglia have been 
exposed to heat-killed GBS strains, and it was shown 
that the number of the viable cells, were significantly 
lower in bacterial-treated cells, than in control wells 
(14), with adverse effect of time and bacterial dose (7, 
9). Moreover, it was shown by them that live GBS strains 
induced significantly higher and faster cell death, in 
comparison to heat-killed strains. In the current study, 
bacterial dose-dependence of MTT assay followed the 
previous studies, and the results showed that viability 
of invasive GBS treated macrophages, were significantly 
lower than colonizing GBS treated macrophages. 
CD40 - CD40L engagement is crucial for microglial 
activation and neurotoxin production, which leads to 
the pathology of neuro inflammatory diseases, following 
chronic inflammation (15). In this study, it was indicated 
that invasive GBS strains, induced higher CD40 
expression on macrophages, in compare to colonizing 
GBS strains. 
CONCLUSIONS
It was proven in this study that all selected markers as 
representative for immune response, have shown that 
invasive GBS strains had more effects on two selected 
immune cells, in comparison to colonizing GBS strains. 
Although some of the results were not statistically 
significant. Moreover, clinical data showed that patients, 
from whom invasive GBS samples were isolated from, 
had severe clinical conditions and the high rate of 
fatality, in comparison to the patients that colonizing 
GBS samples were isolated from. 
There were no sufficient data on the similar classification 
in previous studies, and GBS strains were classified into 
invasive and non-invasive groups, according to different 
criteria such as being hemolytic or non-hemolytic, the 
frequency of the serotypes isolated from neonates with 
sepsis (serotype III showed the most frequency), and the 
patients’ symptoms that the samples were isolated from 
(16, 17). However, in the current study GBS strains were 
classified based on the isolations whereby the samples 
which were isolated from blood were considered as 
invasive GBS strains, and the samples which were 
isolated from HVS as colonizing strains. Hence the 
results of this study were supported by the most relevant 
studies, as it has been discussed above. 
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